Treatment Updates in Advanced Thymoma and Thymic Carcinoma
- 8 September 2012
- journal article
- Published by Springer Nature in Current Treatment Options in Oncology
- Vol. 13 (4) , 527-534
Abstract
Thymomas and thymic carcinomas are rare diseases of the anterior mediastinum. Although some thymomas are quite indolent and able to be resected in a curative fashion, the treatment of metastatic disease remains a challenge, especially for the more aggressive thymic carcinoma histology. Based on the results of single-arm trials, combination chemotherapy is the standard of care in the first-line, and anthracycline-based treatments should be used if patients are reasonably fit. Several single-agent cytotoxic chemotherapy agents have some effectiveness in subsequent lines of therapy, especially pemetrexed and, in octreotide scan-positive patients, octreotide. Prospective trials of new agents are difficult to conduct given the rarity of thymoma, but various targeted therapies do show promise. Greater international research collaboration, as well as modern techniques in molecular and genomic characterization, should help to advance the treatment of thymic malignancies in the near future.Keywords
This publication has 33 references indexed in Scilit:
- Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic CarcinomaJournal of Clinical Oncology, 2011
- Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial TumorsJournal of Clinical Oncology, 2011
- International Thymic Malignancies Interest Group: A Way ForwardJournal of Thoracic Oncology, 2010
- Surgical Treatment of Recurrent ThymomasJournal of Thoracic Oncology, 2010
- Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and ThymomasClinical Cancer Research, 2009
- Imatinib Mesylate in Patients with WHO B3 Thymomas and Thymic CarcinomasJournal of Thoracic Oncology, 2009
- Thymomas: Review of Current Clinical PracticeThe Annals of Thoracic Surgery, 2009
- Protein expression and gene amplification of epidermal growth factor receptor in thymomasCancer, 2005
- Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignanciesInternational Journal of Cancer, 2003
- Chemotherapy for invasive thymoma. A 13-year experienceCancer, 1991